Santen Pharmaceutical Co., Ltd. (4536.T)

Home
4536.T
Financials

1663.5 (JPY) • At close July 30, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Revenue Numbers are in millions	300,004	301,965	279,037	266,257	249,605	241,555	234,026	224,942	199,096	195,291	161,831	148,663	119,066	114,416	110,812	110,594	101,618	103,394	100,485	98,397	92,696
Cost of Revenue Numbers are in millions	137,789	138,089	112,950	109,671	98,221	94,831	90,764	86,378	74,966	72,829	56,373	58,104	41,501	35,385	34,436	34,710	35,947	36,513	35,483	34,534	33,709
Gross Profit Numbers are in millions	162,215	163,876	166,087	156,586	151,384	146,724	143,262	138,564	124,130	122,462	105,458	90,559	77,565	79,031	76,376	75,884	65,671	66,881	65,002	63,863	58,987
Gross Profit Ratio Numbers are in millions	0.541	0.543	0.595	0.588	0.606	0.607	0.612	0.616	0.623	0.627	0.652	0.609	0.651	0.691	0.689	0.686	0.646	0.647	0.647	0.649	0.636
Reseach & Development Expenses Numbers are in millions	24,103	24,703	28,297	26,377	24,112	23,341	23,759	24,398	22,786	19,990	17,477	19,040	16,719	0	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	0	91,529	96,257	84,499	79,554	73,360	71,273	68,788	44,984	43,144	35,851	37,353	0	0	0	0	0	0	0	0	0
Selling & Marketing Expenses Numbers are in millions	0	-4,259	0	0	0	0	0	0	15,950	15,238	12,223	6,751	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	87,967	87,270	96,257	84,499	79,554	73,360	71,273	68,788	60,934	58,382	48,074	44,104	36,164	0	0	0	0	0	0	0	0
Other Expenses Numbers are in millions	0	0	44,623	9,824	34,802	16,488	3,132	6,687	6,672	-37,113	3,714	154	156	881	833	720	861	987	455	223	245
Operating Expenses Numbers are in millions	112,070	111,973	169,177	120,700	138,468	113,189	98,164	99,873	91,651	42,283	70,084	63,144	52,883	52,298	45,636	46,244	50,177	46,510	44,589	42,868	40,003
Operating Income Numbers are in millions	50,145	38,541	-3,090	35,886	12,917	33,535	45,098	38,691	32,479	80,180	35,374	27,414	24,681	26,733	30,738	29,640	15,494	20,370	20,412	20,995	18,982
Operating Income Ratio Numbers are in millions	0.167	0.128	-0.011	0.135	0.052	0.139	0.193	0.172	0.163	0.411	0.219	0.184	0.207	0.234	0.277	0.268	0.152	0.197	0.203	0.213	0.205
Total Other Income Expenses Net Numbers are in millions	-1,979	-8,667	-2,709	-270	-499	-1,444	-1,981	570	-657	-710	489	-2,985	910	1,058	336	-1,030	329	112	627	-654	-546
Income Before Tax Numbers are in millions	48,166	29,874	-5,799	35,616	12,418	32,091	43,117	39,261	31,822	79,470	35,863	26,893	25,591	27,791	31,074	28,610	15,823	20,482	21,039	20,341	18,436
Income Before Tax Ratio Numbers are in millions	0.161	0.099	-0.021	0.134	0.05	0.133	0.184	0.175	0.16	0.407	0.222	0.181	0.215	0.243	0.28	0.259	0.156	0.198	0.209	0.207	0.199
Income Tax Expense Numbers are in millions	11,628	3,171	9,184	8,427	5,773	10,377	11,174	4,000	8,768	26,097	11,831	9,783	9,070	10,630	9,741	9,887	5,700	7,832	7,892	7,320	7,412
Net Income Numbers are in millions	36,247	26,642	-14,948	27,218	6,830	23,618	31,943	35,261	23,054	53,373	24,032	17,109	16,520	17,160	21,333	18,722	10,123	12,650	13,147	13,022	11,022
Net Income Ratio Numbers are in millions	0.121	0.088	-0.054	0.102	0.027	0.098	0.136	0.157	0.116	0.273	0.149	0.115	0.139	0.15	0.193	0.169	0.1	0.122	0.131	0.132	0.119
EPS Numbers are in millions	103.98	72.62	-38.6	68.07	17.1	59.16	78.64	86.76	52.96	128.99	58.18	47.78	39.16	39.39	49.94	44.02	23.82	29.23	30.32	30.05	25.17
EPS Diluted Numbers are in millions	103.68	72.37	-38.6	67.97	17.06	59.01	78.41	86.45	52.76	128.41	57.93	47.63	39.1	39.35	49.88	43.97	23.79	29.19	30.26	30	25.14
EBITDA Numbers are in millions	68,830	56,457	14,298	54,524	30,007	49,415	54,091	50,352	39,998	88,904	42,912	33,208	28,887	30,762	34,086	32,083	20,097	25,171	26,247	25,588	23,689
EBITDA Ratio Numbers are in millions	0.229	0.187	0.051	0.205	0.12	0.205	0.231	0.224	0.201	0.455	0.265	0.223	0.243	0.269	0.308	0.29	0.198	0.243	0.261	0.26	0.256

Santen Pharmaceutical Co., Ltd.

TSE:4536.T Add to watchlist

TSE:4536.T